Reed Vaughn Tuckson

Insider Reports History

Entity
Individual
Location
C/O Unitedhealth Group Incorporated, 9900 Bren Road East, Minnetonka, MN
Signature
/s/ John Rakow, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Reed Vaughn Tuckson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HENRY SCHEIN INC Director Common Stock, par value $0.01 per share 8.16K $624K $76.50 Mar 4, 2024 Direct
Adverum Biotechnologies, Inc. Director Stock Option (Right to Buy) 10.5K Jun 17, 2024 Direct
CTI BIOPHARMA CORP Director Common Stock 0 $9.10 Jun 26, 2023 Direct
CTI BIOPHARMA CORP Director Stock Option (Right to Buy) 0 Jun 26, 2023 Direct

Insider Reports Filed by Reed Vaughn Tuckson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADVM Adverum Biotechnologies, Inc. Jun 17, 2024 1 $0 4 Jun 20, 2024 Director
HSIC HENRY SCHEIN INC Mar 1, 2024 2 -$38.1K 4 Mar 5, 2024 Director
CTIC CTI BIOPHARMA CORP Jun 26, 2023 8 -$443K 4 Jun 26, 2023 Director
ADVM Adverum Biotechnologies, Inc. Jun 9, 2023 1 $0 4 Jun 13, 2023 Director
CTIC CTI BIOPHARMA CORP Apr 5, 2023 1 $0 4 Apr 7, 2023 Director
HSIC HENRY SCHEIN INC Mar 16, 2023 1 -$34.9K 4 Mar 17, 2023 Director
HSIC HENRY SCHEIN INC Mar 1, 2023 1 $0 4 Mar 3, 2023 Director
CTIC CTI BIOPHARMA CORP Dec 31, 2022 1 $0 5 Feb 14, 2023 Director
ADVM Adverum Biotechnologies, Inc. Jun 10, 2022 1 $0 4 Jun 14, 2022 Director
HSIC HENRY SCHEIN INC Mar 16, 2022 1 $0 4 Mar 18, 2022 Director
CTIC CTI BIOPHARMA CORP Mar 9, 2022 1 $0 4 Mar 11, 2022 Director
HSIC HENRY SCHEIN INC Jun 11, 2021 1 $0 4 Jun 15, 2021 Director
HSIC HENRY SCHEIN INC May 13, 2021 0 $0 3 May 19, 2021 Director